Back to top

Septerna initiated with a Buy at H.C. Wainwright

H.C. Wainwright initiated coverage of Septerna (SEPN) with a Buy rating and $26 price target Septerna is an early stage biotechnology company focus...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Septerna, Inc. (SEPN)